Analysis Life Sciences Thank You 166 guidance documents the FDA is actively working on in 2024 (and beyond)
Agency IQ
FEBRUARY 15, 2024
CDRH FY2024 Guidance Agenda Clinical application Recommendations for Investigational and Licensed COVID-19 Convalescent Plasma CBER Final By 12/31/24 CBER CY 2024 Guidance Agenda Blood Considerations for the Development of Blood Collection, Processing, and Storage Systems for the Manufacture of Blood Components Using the Buffy Coat Method CBER Draft (..)
40 
Let's personalize your content